CRM setup for biotech companies

Quick answer

Setting up a CRM for a biotech company means configuring it for how science buys: deals tracked by account with the full lab committee attached, custom fields for funding source and timing, research area and technical evaluation status, and stages built for long, research-driven cycles. The CRM brand matters less than the configuration. Pick a simple one your team will keep updated, then build stages, fields and hygiene rules that fit scientific buyers, lab procurement and grant cycles, so a deal that moves on funding timelines stays legible for months.

Why biotech needs a different CRM setup

A CRM configured for a fast, single-buyer SaaS deal will quietly mislead you in biotech. The default fields assume one contact, a short cycle and a discretionary budget. A biotech deal has none of those.

The buyer is a group of scientists and administrators, the cycle runs for months on grant timing, and the thing that advances the deal is a data evaluation, not a proposal. If your CRM cannot record who is in the lab committee, where the funding comes from and whether the science has been validated, your pipeline will look like a list of stalled single contacts. For the general setup process this builds on, see how to set up a CRM. This article adapts it for the scientific and lab buyers described on our biotech go-to-market page.

Which CRM should a biotech startup pick?

For most early-stage biotech companies, simpler is better. The right CRM is the one your small team will actually keep current, that your tools integrate with, and that you can configure yourself without hiring a consultant.

The usual choice is between a lighter, faster-to-set-up tool and a heavier platform you grow into. At early stage, a long sales cycle is an argument for something you can keep clean for months with low effort, not for enterprise complexity you will half-configure. We walk through the trade-offs in best CRM for startups. Whatever you choose, the configuration below is what makes it work for biotech.

How should you structure accounts and the committee?

Track deals by account, with every member of the lab committee attached as a contact in a defined role. A single "contact" almost never represents a biotech opportunity. Gartner has found that the typical B2B buying group involves six to ten decision makers, and life-sciences deals sit at the higher end.

Set up contact roles that mirror how the lab actually buys:

• Principal investigator or lab lead: the champion who judges the science.
• Scientists and end users: evaluate the data and reproducibility.
• Procurement or lab manager: runs purchasing and the budget.
• Finance or grant administrator: funds within grant cycles.

With roles attached to the account, you can see at a glance whether a deal has a champion but no procurement path, or strong scientific interest but no identified funding. That is the difference between a real opportunity and a hopeful one. For finding and mapping these people in the first place, see how to find and reach biotech buyers.

What custom fields does a biotech CRM need?

A few custom fields turn a generic CRM into one that fits science. Add only fields you will maintain and report on; every unused required field is a tax on the team forever.

The funding fields are the ones startups skip and later regret. Without them, you cannot tell an optimistic forecast from a realistic one, because a fully qualified deal may still be months from a funding window. How these fields map onto stages is covered in CRM pipeline stages and, for biotech specifically, in how to build a sales pipeline for biotech.

How do you build stages that fit long research cycles?

Build stages that each represent a real change in a scientific buyer's commitment, with a clear exit criterion, rather than internal tasks. For a biotech motion that usually means: target identified, scientific conversation, technical evaluation, procurement and budget, funding confirmed, closed.

The principle is the same as any good pipeline, that a stage marks buyer commitment and not seller activity, applied to a buyer who commits by validating data and confirming funding. See CRM pipeline stages for the general rules, and the full biotech stage model in how to build a sales pipeline for biotech.

How do you keep a biotech CRM clean over a long cycle?

Data hygiene matters more, not less, when cycles run for months. A dropped follow-up or a stale record in a nine-month deal is often a lost deal, because the window to re-engage may be tied to funding you cannot recreate.

Set simple rules from day one: deduplication, a naming convention for accounts and labs, clear ownership of each record, and a required next step with a date on every open opportunity. The last one is the quiet workhorse in long cycles, because it stops deals from going silent between stakeholder meetings. Decide your required fields deliberately and keep them few, so the team keeps the CRM current instead of working around it.

Where Enablemnt fits

Everything above is the setup work: the right CRM, accounts and committees, custom funding and evaluation fields, stages for long cycles, and hygiene rules that hold up over months. You can configure it yourself over a few weeks, or have operators who have built it before do it with you.

Enablemnt is your embedded RevOps team. In a fixed 14-day sprint we stand up a clean CRM configured for biotech: accounts with the full lab committee, the funding and evaluation fields that make research-driven deals legible, stages that fit long cycles, and hygiene rules so it stays usable. We also load it with a data-backed target list and live outreach, so it is a working system, not an empty shell. You own all of it at the end, documented.

If you would rather have a biotech-ready CRM built and loaded than configure one yourself, tell us about your company and we will map your GTM blueprint on a short call.

Filed under By industry. Written by Enablemnt AI.